World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
出版年份 2012 全文链接
标题
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
作者
关键词
-
出版物
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Volume 14, Issue 1, Pages 2-44
出版商
Informa UK Limited
发表日期
2012-12-06
DOI
10.3109/15622975.2012.739708
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial
- (2012) Reinhold Kilian et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Tetrabenazine for the Treatment of Tardive Dyskinesia
- (2011) Jonathan G Leung et al. ANNALS OF PHARMACOTHERAPY
- Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
- (2011) Angela L Hill et al. BMC Psychiatry
- Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics
- (2011) Jimmi Nielsen et al. CNS DRUGS
- Evidence-based pharmacotherapy of schizophrenia
- (2011) Stefan Leucht et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine
- (2011) Vicki Poole Hoffmann et al. JOURNAL OF CLINICAL PSYCHIATRY
- Mid-Term and Long-Term Efficacy and Effectiveness of Antipsychotic Medications for Schizophrenia
- (2011) Ira D. Glick et al. JOURNAL OF CLINICAL PSYCHIATRY
- An International Consensus Study of Neuroleptic Malignant Syndrome Diagnostic Criteria Using the Delphi Method
- (2011) Ronald J. Gurrera et al. JOURNAL OF CLINICAL PSYCHIATRY
- Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study
- (2011) Itzhak Kimiagar et al. JOURNAL OF NEUROLOGY
- Deep Brain Stimulation: Current and Future Clinical Applications
- (2011) Mark K. Lyons MAYO CLINIC PROCEEDINGS
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia
- (2011) Robert A. Rosenheck et al. NEW ENGLAND JOURNAL OF MEDICINE
- A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
- (2011) Huafang Li et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia
- (2011) David C. Henderson et al. SCHIZOPHRENIA RESEARCH
- Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidone
- (2011) Jennifer Kern Sliwa et al. SCHIZOPHRENIA RESEARCH
- Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials
- (2011) Claudia Leucht et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms
- (2011) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature
- (2011) Peter Manu et al. SCHIZOPHRENIA RESEARCH
- Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
- (2011) Larry Alphs et al. Annals of General Psychiatry
- Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial
- (2010) Chuan-Yue Wang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
- (2010) Holland C Detke et al. BMC Psychiatry
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism
- (2010) David P McDonnell et al. BMC Psychiatry
- Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis
- (2010) Samir Kumar Praharaj et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management
- (2010) Richard I. G. Holt et al. CLINICAL ENDOCRINOLOGY
- Trazodone for the Treatment of Neuroleptic-Induced Acute Akathisia
- (2010) Rafael Stryjer et al. CLINICAL NEUROPHARMACOLOGY
- Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone
- (2010) M.A. Crocq et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Second-generation antipsychotics and constipation: A review of the literature
- (2010) M. De Hert et al. EUROPEAN PSYCHIATRY
- Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study
- (2010) Srihari Gopal et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Dose correspondence between olanzapine long-acting injection and oral olanzapine
- (2010) Holland C. Detke et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Designing outcome studies to determine efficacy and safety of antipsychotics for ‘real world’ treatment of schizophrenia
- (2010) A. Carlo Altamura et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity
- (2010) Evgueni Tchoukhine et al. JOURNAL OF CLINICAL PSYCHIATRY
- Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention
- (2010) Wolfgang Gaebel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
- (2010) Stanley N. Caroff et al. JOURNAL OF CLINICAL PSYCHIATRY
- Strategies for Improving Treatment Adherence in Schizophrenia and Schizoaffective Disorder
- (2010) Donald C. Goff et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
- (2010) Gahan J. Pandina et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study
- (2010) MRA Muscatello et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
- (2010) S Gopal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
- (2010) Henry A Nasrallah et al. NEUROPSYCHOPHARMACOLOGY
- Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
- (2010) Wolfgang Gaebel et al. NEUROPSYCHOPHARMACOLOGY
- A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
- (2010) Gahan Pandina et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial
- (2010) Preeta Kaur Narula et al. SCHIZOPHRENIA RESEARCH
- Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
- (2010) Jean-Pierre Lindenmayer et al. SCHIZOPHRENIA RESEARCH
- A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia
- (2009) D. C. Henderson et al. ACTA PSYCHIATRICA SCANDINAVICA
- How to read and understand and use systematic reviews and meta-analyses
- (2009) S. Leucht et al. ACTA PSYCHIATRICA SCANDINAVICA
- Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
- (2009) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder
- (2009) Thomas Munk Laursen et al. ARCHIVES OF GENERAL PSYCHIATRY
- Antipsychotic long-acting injections: Mind the gap
- (2009) Maxine X. Patel et al. BRITISH JOURNAL OF PSYCHIATRY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia
- (2009) S. Gopal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Tardive dyskinesia and new antipsychotics
- (2009) Christoph U Correll et al. CURRENT OPINION IN PSYCHIATRY
- Akathisia and second-generation antipsychotic drugs
- (2009) Rajeev Kumar et al. CURRENT OPINION IN PSYCHIATRY
- Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)
- (2009) J.M. Olivares et al. EUROPEAN PSYCHIATRY
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication
- (2009) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study
- (2009) Michelle Kramer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine
- (2009) John W. Newcomer et al. JOURNAL OF CLINICAL PSYCHIATRY
- An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia
- (2009) John Lauriello et al. JOURNAL OF CLINICAL PSYCHIATRY
- Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity
- (2009) Grigori Joffe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia
- (2009) Lone Baandrup et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized Controlled Trial of Long-Acting Injectable Risperidone vs Continuation on Oral Atypical Antipsychotics for First-Episode Schizophrenia Patients
- (2009) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHIATRY
- Reduction in Neuroleptic-Induced Movement Disorders After a Switch to Quetiapine in Patients With Schizophrenia
- (2009) Leonardo Cortese et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia
- (2009) DE Tenback et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial
- (2009) T. Baptista et al. PHARMACOPSYCHIATRY
- Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia
- (2009) David Hough et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: Eight-week randomized, single-blind, placebo-controlled, multicenter study
- (2009) Moon-Soo Lee et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
- (2009) Julie Kreyenbuhl et al. SCHIZOPHRENIA BULLETIN
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
- (2009) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
- (2009) David Hough et al. SCHIZOPHRENIA RESEARCH
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania
- (2009) Heinz Grunze et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
- (2008) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Role of Metformin for Weight Management in Patients Without Type 2 Diabetes
- (2008) Alicia R Desilets et al. ANNALS OF PHARMACOTHERAPY
- Do effectiveness (“real world”) studies on antipsychotics tell us the real truth?
- (2008) Hans-Jürgen Möller EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
- (2008) Robin Emsley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Olanzapine pamoate: a stick in time?
- (2008) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Randomized, Crossover Comparison of Herbal Medicine and Bromocriptine Against Risperidone-Induced Hyperprolactinemia in Patients With Schizophrenia
- (2008) Hai-Ning Yuan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
- (2008) H Afshar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
- (2008) S Leucht et al. MOLECULAR PSYCHIATRY
- Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia
- (2008) Wataru Sako et al. MOVEMENT DISORDERS
- Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole
- (2008) Mong-Liang Lu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study
- (2008) Trino Baptista et al. PSYCHIATRY RESEARCH
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review
- (2008) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- Does switching to a new antipsychotic improve outcomes?
- (2008) Robert A Rosenheck et al. SCHIZOPHRENIA RESEARCH
- Results of phase 3 of the CATIE schizophrenia trial
- (2008) T. Scott Stroup et al. SCHIZOPHRENIA RESEARCH
- How to grade categories of evidence
- (2008) Borwin Bandelow et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
- (2008) Borwin Bandelow et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Employment Outcomes in a Randomized Trial of Second-Generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia
- (2008) Sandra G. Resnick et al. JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH
- Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia
- (2007) Peter M. Wehmeier et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine
- (2007) Chun-Hsin Chen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started